Molecular Basis of Mitochondrial Myopathies: Polypeptide Analysis in Complex-I Deficiency
Overview
Affiliations
Clinical and biochemical data are reported for three patients with mitochondrial myopathy. One patient presented only with exercise-induced muscle weakness, whereas the other two showed signs of multisystem disease. Polarographic determination of oxygen uptake in skeletal muscle mitochondria suggested complex-I (nicotinamide adenine dinucleotide [reduced] ubiquinone oxidoreductase) deficiency. Sodium dodecyl sulphate polyacrylamide gel electrophoresis and immunoblotting with antibody to the holoenzyme of complex-I and specific antibodies to certain of the Fe-S subunits of complex-I showed a relatively normal profile in the least affected patient and a generalised reduction in the intensities of all crossreacting bands in the other two patients. The most severely affected patient also showed a disproportionate and pronounced reduction in the 24 K Fe-S subunit. Clinical severity of muscle involvement correlated with the biochemical deficiency as determined polarographically and with the immunoblot appearances.
Schapira A CNS Drugs. 2011; 25(12):1061-71.
PMID: 22133327 DOI: 10.2165/11596310-000000000-00000.
Mitochondrial contribution to Parkinson's disease pathogenesis.
Schapira A, Gegg M Parkinsons Dis. 2011; 2011:159160.
PMID: 21687805 PMC: 3109314. DOI: 10.4061/2011/159160.
Mitochondrial matters of the brain: the role in Huntington's disease.
Turner C, Schapira A J Bioenerg Biomembr. 2010; 42(3):193-8.
PMID: 20480217 DOI: 10.1007/s10863-010-9290-y.
Mitochondrial dysfunction in neurodegenerative diseases.
Schapira A Neurochem Res. 2008; 33(12):2502-9.
PMID: 18998208 DOI: 10.1007/s11064-008-9855-x.
Mitochondrial disease: a historical, biochemical, and London perspective.
Land J, Morgan-Hughes J, Hargreaves I, Heales S Neurochem Res. 2004; 29(3):483-91.
PMID: 15038596 DOI: 10.1023/b:nere.0000014819.53972.b0.